925 Shares in HCA Healthcare, Inc. $HCA Purchased by Compound Planning Inc.

Key Points

• Compound Planning Inc. has acquired a new stake in HCA Healthcare, Inc. by purchasing 925 shares, valued at approximately $320,000.
• HCA Healthcare reported strong quarterly earnings, with EPS of $6.84, exceeding estimates, and revenue growth of 6.4% year over year.
• The company declared a quarterly dividend of $0.72, which translates to an annualized rate of $2.88 and a dividend yield of 0.7%.

Compound Planning Inc. bought a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 925 shares of the company's stock, valued at approximately $320,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HCA. Cheviot Value Management LLC purchased a new position in shares of HCA Healthcare during the 1st quarter worth $26,000. Atwood & Palmer Inc. acquired a new stake in HCA Healthcare in the 1st quarter worth about $28,000. Bartlett & CO. Wealth Management LLC increased its stake in shares of HCA Healthcare by 888.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after acquiring an additional 80 shares during the last quarter. ORG Partners LLC grew its holdings in HCA Healthcare by 344.0% in the first quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after purchasing an additional 86 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. raised its stake in HCA Healthcare by 75.8% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock worth $40,000 after purchasing an additional 50 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on HCA. Bank of America lowered HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 target price on the stock. in a research report on Wednesday, July 16th. Wolfe Research lowered HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Royal Bank Of Canada cut their price target on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a report on Monday, July 28th. Cantor Fitzgerald reissued an "overweight" rating and issued a $444.00 price objective on shares of HCA Healthcare in a research report on Tuesday. Finally, Truist Financial upped their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research report on Wednesday, July 16th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $401.83.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $405.18 on Thursday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The stock has a market cap of $94.81 billion, a P/E ratio of 17.03, a price-to-earnings-growth ratio of 1.26 and a beta of 1.39. The stock has a 50 day moving average of $375.76 and a 200-day moving average of $355.47.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the business earned $5.50 EPS. The firm's revenue for the quarter was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's payout ratio is 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.